Also known as: Bremelanotide; Vyleesi (brand); Melanotan II analogue
PT141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. It acts centrally through melanocortin receptors to stimulate sexual arousal and is approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.
| Parameter | Specification |
|---|---|
| CAS Number | 189691-06-3 |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.16 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Melanocortin Receptor Agonist / Sexual Dysfunction Treatment |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PT141/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying PT141 — CAS 189691-06-3 (CAS 189691-06-3) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our PT141 — CAS 189691-06-3 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance